Pediatric Drugs and Vaccines-United States Market Status and Trend Report 2013-2023
Report Summary
Pediatric Drugs and Vaccines-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Pediatric Drugs and Vaccines industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Pediatric Drugs and Vaccines 2013-2017, and development forecast 2018-2023
Main market players of Pediatric Drugs and Vaccines in United States, with company and product introduction, position in the Pediatric Drugs and Vaccines market
Market status and development trend of Pediatric Drugs and Vaccines by types and applications
Cost and profit status of Pediatric Drugs and Vaccines, and marketing status
Market growth drivers and challenges
The report segments the United States Pediatric Drugs and Vaccines market as:
United States Pediatric Drugs and Vaccines Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Pediatric Drugs and Vaccines Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Mumps
Others
United States Pediatric Drugs and Vaccines Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Newborn
Infant
Child
United States Pediatric Drugs and Vaccines Market: Players Segment Analysis (Company and Product introduction, Pediatric Drugs and Vaccines Sales Volume, Revenue, Price and Gross Margin):
Merck & Co., Inc. (USA)
Abbott Laboratories (USA)
Amgen, Inc. (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals Ltd (Switzerland)(A Janssen Pharmaceutical Company)
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Allergan, Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Shire Pharmaceuticals Group Plc. (UK)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Pediatric Drugs and Vaccines-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Pediatric Drugs and Vaccines industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Pediatric Drugs and Vaccines 2013-2017, and development forecast 2018-2023
Main market players of Pediatric Drugs and Vaccines in United States, with company and product introduction, position in the Pediatric Drugs and Vaccines market
Market status and development trend of Pediatric Drugs and Vaccines by types and applications
Cost and profit status of Pediatric Drugs and Vaccines, and marketing status
Market growth drivers and challenges
The report segments the United States Pediatric Drugs and Vaccines market as:
United States Pediatric Drugs and Vaccines Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Pediatric Drugs and Vaccines Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Mumps
Others
United States Pediatric Drugs and Vaccines Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Newborn
Infant
Child
United States Pediatric Drugs and Vaccines Market: Players Segment Analysis (Company and Product introduction, Pediatric Drugs and Vaccines Sales Volume, Revenue, Price and Gross Margin):
Merck & Co., Inc. (USA)
Abbott Laboratories (USA)
Amgen, Inc. (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals Ltd (Switzerland)(A Janssen Pharmaceutical Company)
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Allergan, Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Shire Pharmaceuticals Group Plc. (UK)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF PEDIATRIC DRUGS AND VACCINES
1.1 Definition of Pediatric Drugs and Vaccines in This Report
1.2 Commercial Types of Pediatric Drugs and Vaccines
1.2.1 Diphtheria
1.2.2 Influenza
1.2.3 Hepatitis
1.2.4 Pneumococcal Diseases
1.2.5 Meningococcal Diseases
1.2.6 Mumps
1.2.7 Others
1.3 Downstream Application of Pediatric Drugs and Vaccines
1.3.1 Newborn
1.3.2 Infant
1.3.3 Child
1.4 Development History of Pediatric Drugs and Vaccines
1.5 Market Status and Trend of Pediatric Drugs and Vaccines 2013-2023
1.5.1 United States Pediatric Drugs and Vaccines Market Status and Trend 2013-2023
1.5.2 Regional Pediatric Drugs and Vaccines Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Pediatric Drugs and Vaccines in United States 2013-2017
2.2 Consumption Market of Pediatric Drugs and Vaccines in United States by Regions
2.2.1 Consumption Volume of Pediatric Drugs and Vaccines in United States by Regions
2.2.2 Revenue of Pediatric Drugs and Vaccines in United States by Regions
2.3 Market Analysis of Pediatric Drugs and Vaccines in United States by Regions
2.3.1 Market Analysis of Pediatric Drugs and Vaccines in New England 2013-2017
2.3.2 Market Analysis of Pediatric Drugs and Vaccines in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Pediatric Drugs and Vaccines in The Midwest 2013-2017
2.3.4 Market Analysis of Pediatric Drugs and Vaccines in The West 2013-2017
2.3.5 Market Analysis of Pediatric Drugs and Vaccines in The South 2013-2017
2.3.6 Market Analysis of Pediatric Drugs and Vaccines in Southwest 2013-2017
2.4 Market Development Forecast of Pediatric Drugs and Vaccines in United States 2018-2023
2.4.1 Market Development Forecast of Pediatric Drugs and Vaccines in United States 2018-2023
2.4.2 Market Development Forecast of Pediatric Drugs and Vaccines by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Pediatric Drugs and Vaccines in United States by Types
3.1.2 Revenue of Pediatric Drugs and Vaccines in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Pediatric Drugs and Vaccines in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Pediatric Drugs and Vaccines in United States by Downstream Industry
4.2 Demand Volume of Pediatric Drugs and Vaccines by Downstream Industry in Major Countries
4.2.1 Demand Volume of Pediatric Drugs and Vaccines by Downstream Industry in New England
4.2.2 Demand Volume of Pediatric Drugs and Vaccines by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Pediatric Drugs and Vaccines by Downstream Industry in The Midwest
4.2.4 Demand Volume of Pediatric Drugs and Vaccines by Downstream Industry in The West
4.2.5 Demand Volume of Pediatric Drugs and Vaccines by Downstream Industry in The South
4.2.6 Demand Volume of Pediatric Drugs and Vaccines by Downstream Industry in Southwest
4.3 Market Forecast of Pediatric Drugs and Vaccines in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF PEDIATRIC DRUGS AND VACCINES
5.1 United States Economy Situation and Trend Overview
5.2 Pediatric Drugs and Vaccines Downstream Industry Situation and Trend Overview
CHAPTER 6 PEDIATRIC DRUGS AND VACCINES MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Pediatric Drugs and Vaccines in United States by Major Players
6.2 Revenue of Pediatric Drugs and Vaccines in United States by Major Players
6.3 Basic Information of Pediatric Drugs and Vaccines by Major Players
6.3.1 Headquarters Location and Established Time of Pediatric Drugs and Vaccines Major Players
6.3.2 Employees and Revenue Level of Pediatric Drugs and Vaccines Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 PEDIATRIC DRUGS AND VACCINES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Merck & Co., Inc. (USA)
7.1.1 Company profile
7.1.2 Representative Pediatric Drugs and Vaccines Product
7.1.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Merck & Co., Inc. (USA)
7.2 Abbott Laboratories (USA)
7.2.1 Company profile
7.2.2 Representative Pediatric Drugs and Vaccines Product
7.2.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Abbott Laboratories (USA)
7.3 Amgen, Inc. (USA)
7.3.1 Company profile
7.3.2 Representative Pediatric Drugs and Vaccines Product
7.3.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Amgen, Inc. (USA)
7.4 Eli Lilly and Company (USA)
7.4.1 Company profile
7.4.2 Representative Pediatric Drugs and Vaccines Product
7.4.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Eli Lilly and Company (USA)
7.5 F. Hoffmann-La Roche Ltd (Switzerland)
7.5.1 Company profile
7.5.2 Representative Pediatric Drugs and Vaccines Product
7.5.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche Ltd (Switzerland)
7.6 Genentech, Inc. (USA)
7.6.1 Company profile
7.6.2 Representative Pediatric Drugs and Vaccines Product
7.6.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Genentech, Inc. (USA)
7.7 GlaxoSmithKline plc. (UK)
7.7.1 Company profile
7.7.2 Representative Pediatric Drugs and Vaccines Product
7.7.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of GlaxoSmithKline plc. (UK)
7.8 Janssen Biologics B.V. (USA)
7.8.1 Company profile
7.8.2 Representative Pediatric Drugs and Vaccines Product
7.8.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Janssen Biologics B.V. (USA)
7.9 Actelion Pharmaceuticals Ltd (Switzerland)(A Janssen Pharmaceutical Company)
7.9.1 Company profile
7.9.2 Representative Pediatric Drugs and Vaccines Product
7.9.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Actelion Pharmaceuticals Ltd (Switzerland)(A Janssen Pharmaceutical Company)
7.10 AstraZeneca Plc. (UK)
7.10.1 Company profile
7.10.2 Representative Pediatric Drugs and Vaccines Product
7.10.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of AstraZeneca Plc. (UK)
7.11 Boehringer Ingelheim GmbH (Germany)
7.11.1 Company profile
7.11.2 Representative Pediatric Drugs and Vaccines Product
7.11.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim GmbH (Germany)
7.12 Bristol-Myers Squibb Company (USA)
7.12.1 Company profile
7.12.2 Representative Pediatric Drugs and Vaccines Product
7.12.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Bristol-Myers Squibb Company (USA)
7.13 Allergan, Inc. (USA)
7.13.1 Company profile
7.13.2 Representative Pediatric Drugs and Vaccines Product
7.13.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Allergan, Inc. (USA)
7.14 Novartis AG (Switzerland)
7.14.1 Company profile
7.14.2 Representative Pediatric Drugs and Vaccines Product
7.14.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Novartis AG (Switzerland)
7.15 Novo Nordisk A/S (Denmark)
7.15.1 Company profile
7.15.2 Representative Pediatric Drugs and Vaccines Product
7.15.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Novo Nordisk A/S (Denmark)
7.16 Pfizer, Inc. (USA)
7.17 Sanofi S.A (France)
7.18 Shionogi Inc. (USA)
7.19 Shire Pharmaceuticals Group Plc. (UK)
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PEDIATRIC DRUGS AND VACCINES
8.1 Industry Chain of Pediatric Drugs and Vaccines
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF PEDIATRIC DRUGS AND VACCINES
9.1 Cost Structure Analysis of Pediatric Drugs and Vaccines
9.2 Raw Materials Cost Analysis of Pediatric Drugs and Vaccines
9.3 Labor Cost Analysis of Pediatric Drugs and Vaccines
9.4 Manufacturing Expenses Analysis of Pediatric Drugs and Vaccines
CHAPTER 10 MARKETING STATUS ANALYSIS OF PEDIATRIC DRUGS AND VACCINES
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Pediatric Drugs and Vaccines in This Report
1.2 Commercial Types of Pediatric Drugs and Vaccines
1.2.1 Diphtheria
1.2.2 Influenza
1.2.3 Hepatitis
1.2.4 Pneumococcal Diseases
1.2.5 Meningococcal Diseases
1.2.6 Mumps
1.2.7 Others
1.3 Downstream Application of Pediatric Drugs and Vaccines
1.3.1 Newborn
1.3.2 Infant
1.3.3 Child
1.4 Development History of Pediatric Drugs and Vaccines
1.5 Market Status and Trend of Pediatric Drugs and Vaccines 2013-2023
1.5.1 United States Pediatric Drugs and Vaccines Market Status and Trend 2013-2023
1.5.2 Regional Pediatric Drugs and Vaccines Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Pediatric Drugs and Vaccines in United States 2013-2017
2.2 Consumption Market of Pediatric Drugs and Vaccines in United States by Regions
2.2.1 Consumption Volume of Pediatric Drugs and Vaccines in United States by Regions
2.2.2 Revenue of Pediatric Drugs and Vaccines in United States by Regions
2.3 Market Analysis of Pediatric Drugs and Vaccines in United States by Regions
2.3.1 Market Analysis of Pediatric Drugs and Vaccines in New England 2013-2017
2.3.2 Market Analysis of Pediatric Drugs and Vaccines in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Pediatric Drugs and Vaccines in The Midwest 2013-2017
2.3.4 Market Analysis of Pediatric Drugs and Vaccines in The West 2013-2017
2.3.5 Market Analysis of Pediatric Drugs and Vaccines in The South 2013-2017
2.3.6 Market Analysis of Pediatric Drugs and Vaccines in Southwest 2013-2017
2.4 Market Development Forecast of Pediatric Drugs and Vaccines in United States 2018-2023
2.4.1 Market Development Forecast of Pediatric Drugs and Vaccines in United States 2018-2023
2.4.2 Market Development Forecast of Pediatric Drugs and Vaccines by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Pediatric Drugs and Vaccines in United States by Types
3.1.2 Revenue of Pediatric Drugs and Vaccines in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Pediatric Drugs and Vaccines in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Pediatric Drugs and Vaccines in United States by Downstream Industry
4.2 Demand Volume of Pediatric Drugs and Vaccines by Downstream Industry in Major Countries
4.2.1 Demand Volume of Pediatric Drugs and Vaccines by Downstream Industry in New England
4.2.2 Demand Volume of Pediatric Drugs and Vaccines by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Pediatric Drugs and Vaccines by Downstream Industry in The Midwest
4.2.4 Demand Volume of Pediatric Drugs and Vaccines by Downstream Industry in The West
4.2.5 Demand Volume of Pediatric Drugs and Vaccines by Downstream Industry in The South
4.2.6 Demand Volume of Pediatric Drugs and Vaccines by Downstream Industry in Southwest
4.3 Market Forecast of Pediatric Drugs and Vaccines in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF PEDIATRIC DRUGS AND VACCINES
5.1 United States Economy Situation and Trend Overview
5.2 Pediatric Drugs and Vaccines Downstream Industry Situation and Trend Overview
CHAPTER 6 PEDIATRIC DRUGS AND VACCINES MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Pediatric Drugs and Vaccines in United States by Major Players
6.2 Revenue of Pediatric Drugs and Vaccines in United States by Major Players
6.3 Basic Information of Pediatric Drugs and Vaccines by Major Players
6.3.1 Headquarters Location and Established Time of Pediatric Drugs and Vaccines Major Players
6.3.2 Employees and Revenue Level of Pediatric Drugs and Vaccines Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 PEDIATRIC DRUGS AND VACCINES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Merck & Co., Inc. (USA)
7.1.1 Company profile
7.1.2 Representative Pediatric Drugs and Vaccines Product
7.1.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Merck & Co., Inc. (USA)
7.2 Abbott Laboratories (USA)
7.2.1 Company profile
7.2.2 Representative Pediatric Drugs and Vaccines Product
7.2.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Abbott Laboratories (USA)
7.3 Amgen, Inc. (USA)
7.3.1 Company profile
7.3.2 Representative Pediatric Drugs and Vaccines Product
7.3.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Amgen, Inc. (USA)
7.4 Eli Lilly and Company (USA)
7.4.1 Company profile
7.4.2 Representative Pediatric Drugs and Vaccines Product
7.4.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Eli Lilly and Company (USA)
7.5 F. Hoffmann-La Roche Ltd (Switzerland)
7.5.1 Company profile
7.5.2 Representative Pediatric Drugs and Vaccines Product
7.5.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche Ltd (Switzerland)
7.6 Genentech, Inc. (USA)
7.6.1 Company profile
7.6.2 Representative Pediatric Drugs and Vaccines Product
7.6.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Genentech, Inc. (USA)
7.7 GlaxoSmithKline plc. (UK)
7.7.1 Company profile
7.7.2 Representative Pediatric Drugs and Vaccines Product
7.7.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of GlaxoSmithKline plc. (UK)
7.8 Janssen Biologics B.V. (USA)
7.8.1 Company profile
7.8.2 Representative Pediatric Drugs and Vaccines Product
7.8.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Janssen Biologics B.V. (USA)
7.9 Actelion Pharmaceuticals Ltd (Switzerland)(A Janssen Pharmaceutical Company)
7.9.1 Company profile
7.9.2 Representative Pediatric Drugs and Vaccines Product
7.9.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Actelion Pharmaceuticals Ltd (Switzerland)(A Janssen Pharmaceutical Company)
7.10 AstraZeneca Plc. (UK)
7.10.1 Company profile
7.10.2 Representative Pediatric Drugs and Vaccines Product
7.10.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of AstraZeneca Plc. (UK)
7.11 Boehringer Ingelheim GmbH (Germany)
7.11.1 Company profile
7.11.2 Representative Pediatric Drugs and Vaccines Product
7.11.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim GmbH (Germany)
7.12 Bristol-Myers Squibb Company (USA)
7.12.1 Company profile
7.12.2 Representative Pediatric Drugs and Vaccines Product
7.12.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Bristol-Myers Squibb Company (USA)
7.13 Allergan, Inc. (USA)
7.13.1 Company profile
7.13.2 Representative Pediatric Drugs and Vaccines Product
7.13.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Allergan, Inc. (USA)
7.14 Novartis AG (Switzerland)
7.14.1 Company profile
7.14.2 Representative Pediatric Drugs and Vaccines Product
7.14.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Novartis AG (Switzerland)
7.15 Novo Nordisk A/S (Denmark)
7.15.1 Company profile
7.15.2 Representative Pediatric Drugs and Vaccines Product
7.15.3 Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin of Novo Nordisk A/S (Denmark)
7.16 Pfizer, Inc. (USA)
7.17 Sanofi S.A (France)
7.18 Shionogi Inc. (USA)
7.19 Shire Pharmaceuticals Group Plc. (UK)
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PEDIATRIC DRUGS AND VACCINES
8.1 Industry Chain of Pediatric Drugs and Vaccines
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF PEDIATRIC DRUGS AND VACCINES
9.1 Cost Structure Analysis of Pediatric Drugs and Vaccines
9.2 Raw Materials Cost Analysis of Pediatric Drugs and Vaccines
9.3 Labor Cost Analysis of Pediatric Drugs and Vaccines
9.4 Manufacturing Expenses Analysis of Pediatric Drugs and Vaccines
CHAPTER 10 MARKETING STATUS ANALYSIS OF PEDIATRIC DRUGS AND VACCINES
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
